Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma - Transactions related to share buy-back program (week 28, 2026)
Company announcement No. 32 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 28, 2026) Copenhagen, Denmark, July 13, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
OneSource Specialty Pharma ties up with Germany's Formycon for Biosimilar manufacturing
OneSource Specialty Pharma Limited announced a strategic manufacturing partnership with Formycon AG, a Munich-based independent biosimilar developer, today. Under the agreement, OneSource will provide integrated Drug Substance and Drug Product…
Natco Pharma raises Adcock Ingram stake to 49%, pays ₹1,060 crore
Hyderabad-based Natco Pharma Limited on Tuesday completed the acquisition of an additional 13.25 per cent equity stake in South African pharmaceutical company Adcock Ingram Holdings Proprietary Limited, bringing its total shareholding to 49 per…
UK caves to pharma demands in Swiss trade deal - despite NHS cost fears
“The U.K. government is risking our healthcare system and the health of patients in order to reduce its ability to legislate and regulate in the interests of the public — and they're doing that in order to please the pharmaceutical…
Athira Pharma (NASDAQ:LONA) Trading Up 13% - Should You Buy?
Athira Pharma, Inc. (NASDAQ:LONA - Get Free Report) shares were up 13% during trading on Monday. The company traded as high as $9.39 and last traded at $9.7950. Approximately 4,884 shares were traded during mid-day trading, a decline of 77% from…
Canal Insurance CO Acquires Shares of 20,000 Royalty Pharma PLC $RPRX
Canal Insurance CO acquired a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 20,000 shares…
NervGen Pharma (NASDAQ:NGEN) Now Covered by Leerink Partners
Leerink Partners assumed coverage on shares of NervGen Pharma (NASDAQ:NGEN - Get Free Report) in a report issued on Monday. The brokerage set an 'outperform' rating and a $10.00 price target on the stock. Leerink Partners' target price suggests a…
Emerald Advisers LLC Sells 20,403 Shares of BridgeBio Pharma, Inc. $BBIO
Emerald Advisers LLC lessened its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 3.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund…
13,665 Shares in BridgeBio Pharma, Inc. $BBIO Purchased by Hsbc Holdings PLC
Hsbc Holdings PLC bought a new stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 13,665 shares of the company's…
Calamos Wealth Management LLC Acquires New Shares in Royalty Pharma PLC $RPRX
Calamos Wealth Management LLC bought a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought…
Pictet Asset Management Holding SA Lowers Stock Position in NewAmsterdam Pharma Company N.V. $NAMS
Pictet Asset Management Holding SA lessened its holdings in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 99.1% during the first quarter, according to the company in its most recent filing with the Securities and…
Germany approves healthcare costs overhaul despite significant pharma opposition
Lawmakers in Germany have passed a bill that will cut health insurance costs in a shakeup that has generated strong resistance from global drugmakers. Germany's Bundestag, the country's primary legislative body and national parliament, gave…
Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi
Mechelen, Belgium; July 13, 2026, 22:01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that following his appointment as Executive Vice President, Global Head of Research & Development Pharma at Sanofi SA, Dr. Paulo…
Nifty Prediction Today - July 14, 2026: Nifty futures: Stays in a range but exhibits bearish tilt
Nifty 50 began today's session with a gap-down at 24,068 versus Monday's close of 24,211. It is now trading at 24,090, down 0.5 per cent. The advance/decline ratio stands at 18/32, showing a bearish bias. Cipla and Bharti Airtel (up 1.3 per cent…
Rare-Disease Families Can Now Invest In Biotech Gene Therapy
A grandfather playing with his grandson in a wheelchair due to a genetic disability of Pitt-Hopkins syndrome. In drug development, patients are the people a therapy is for. They enroll, they wait, they hope. What they almost never do is own a stake…
Receive a Daily briefing on Pharma Industry News
Get Started